Retinoid Adenosine Semi-Crystalline Polymer Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic compositions for addressing skin aging, particularly wrinkles and sagging skin, often require a long time to show visible effects due to the limitations of retinol and other anti-wrinkle active ingredients, necessitating a more immediate and effective solution.
Innovation Solution
A cosmetic or dermatological composition combining retinoids, non-phosphate adenosine compounds, and semi-crystalline polymers with crystallizable side chains, which work together to provide immediate and sustained anti-wrinkle effects by enhancing skin texture and camouflage of wrinkles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If retinol is used as an anti-wrinkle active ingredient, then long-term effectiveness is achieved, but the level must be restricted for tolerance which limits effectiveness and only long-term results are visible
Solution Approach 1:
The patent combines retinol with adenosine and a semi-crystalline polymer in a single cosmetic composition. This merging allows the composition to provide both the long-term effectiveness of retinol and the immediate filling effect of the polymer, while adenosine enhances collagen production. The combination resolves the contradiction by delivering multiple mechanisms of action simultaneously.
Solution Approach 2:
The invention uses a composite formulation containing three distinct active ingredients (retinol, adenosine, and semi-crystalline polymer) that work synergistically. Each component contributes different properties: retinol for cell differentiation, adenosine for collagen stimulation, and the polymer for immediate structural filling. This composite approach allows the composition to overcome the limitations of individual ingredients.
2Reliability
If combinations of retinol with other anti-wrinkle active ingredients like adenosine are used, then effectiveness is enhanced, but the visible effect still only occurs after several days to weeks
Solution Approach 1:
The patent merges retinol, adenosine, and semi-crystalline polymer into a single composition that delivers both immediate and long-term anti-wrinkle effects. The polymer provides instant filling while retinol and adenosine work on collagen production and cell differentiation, achieving visible results much faster than retinol alone.
Solution Approach 2:
The invention changes the physical state parameters by incorporating a semi-crystalline polymer that can provide immediate structural support and filling effects. This physical parameter change (from molecular-level action to macroscopic structural filling) enables visible effects to appear immediately rather than after weeks of application.
3Loss of time
If semi-crystalline polymer with crystallizable side chains is used, then immediate visible effect and skin smoothing are achieved, but the patent does not envisage its use in combination with retinoid and adenosine for reinforced anti-wrinkle effectiveness
Solution Approach 1:
The patent merges the semi-crystalline polymer with retinol and adenosine to create a synergistic composition. The polymer provides immediate filling and smoothing effects, while retinol and adenosine work on long-term collagen production and skin renewal. This combination achieves both immediate visible effects and sustained anti-wrinkle reliability.
Solution Approach 2:
The invention creates a composite material system where the semi-crystalline polymer, retinol, and adenosine work together. The polymer's crystallizable side chains provide structural organization and immediate filling, while the biological actives provide cellular-level improvements. This composite approach achieves both immediate and long-term effectiveness simultaneously.
Data Source
Figure 1
AI summary
Cosmetic/dermatological composition comprises, in a medium, a retinoid or retinoid derivative, an adenosine-based non-phosphated compound, and a semicrystalline polymer with one or more crystallizable side chain(s). ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.